GP-Pharm: Clinical Trials

3 trials sponsored by GP-Pharm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Terminated 1

Follow GP-Pharm: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Leuprolide acetate 22.5 mg depot, GP-Pharm SA - Prostate Cancer
Phase 3CompletedGP-Pharm1632011-09-012017-03-03
Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients
leuprolide acetate - Prostate Cancer
Phase 3TerminatedGP-Pharm202008-05-012010-09-09
Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer
leuprolide acetate - Prostate Cancer
Phase 3CompletedGP-Pharm1202005-09-012007-11-14

Conditions studied

Prostatic Neoplasms (3)  ·  Neoplasms (1)

Interventions

Leuprolide (3)

Countries

United States (3)  ·  Austria (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Slovakia (1)  ·  Spain (1)  ·  United Kingdom (1)

Results publications

PMID 20435244, PMID 30929678